Global Drug Eluting Stents Market: Key Developments
In February 2020, BIOTRONIK, a medical device company, obtained CE Mark certification for Orsiro mission, a drug eluting stent. The stent shows next-level deliverability for acute performance. The stent is used for improving coronary luminal diameter in patients with coronary artery disease. Safety, efficacy, and clinical performance of Orsiro stent have been investigated in clinical studies with more than 48,500 patients enrolled.
Drug Eluting Stents Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients